Diaby, V., Adunlin, G., Ali, A. A., Zeichner, S. B., de Lima Lopes, G., Kohn, C. G., & Montero, A. J. (2016). Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat.
Čikaški stil citiranjaDiaby, Vakaramoko, Georges Adunlin, Askal A. Ali, Simon B. Zeichner, Gilberto de Lima Lopes, Christine G. Kohn, i Alberto J. Montero. "Cost-effectiveness Analysis of 1st Through 3rd Line Sequential Targeted Therapy in HER2-positive Metastatic Breast Cancer in the United States." Breast Cancer Res Treat 2016.
MLA način citiranjaDiaby, Vakaramoko, et al. "Cost-effectiveness Analysis of 1st Through 3rd Line Sequential Targeted Therapy in HER2-positive Metastatic Breast Cancer in the United States." Breast Cancer Res Treat 2016.